Stay updated on Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now indicates that recruitment is closed, and new help/navigation items were added along with a formatting tweak to the Intervention/Treatment header and a revision note showing v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T07:56:41.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.5.5 is now displayed, replacing the previous Revision: v3.5.4, indicating a new build/version of the page.
    Difference
    0.1%
    Check dated 2026-06-08T04:20:21.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4 on the page, indicating a minor update to the study record.
    Difference
    0.1%
    Check dated 2026-05-17T10:09:39.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page’s displayed revision/version identifier was updated from v3.5.2 to v3.5.3, indicating a site or interface software update rather than a change to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-25T18:25:55.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:26:38.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.0 and no longer shows Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T20:00:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page.